Dizlin Competitors and Similar CompaniesClear all
Dizlin's competitors and similar companies include Addex Therapeutics and IRLAB Therapeutics.
 Dizlin Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease. |  Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products. |  IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). | |
Founding Date | Founding Date 2003 | Founding Date 2002 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Göteborg, SE HQ | Locations Plan-les-Ouates, CH HQ San Francisco, US | Locations Göteborg, SE HQ |
Employees | Employees 6 | Employees 23 | Employees 30 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) CHF30k (FY, 2025) | Revenue (est.) kr57.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit CHF173k (FY, 2025) | Gross profit kr62.8m (FY, 2025) |
Net income | Net income N/A | Net income (CHF6.8m) (FY, 2025) | Net income (kr110m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Addex Therapeutics
HQ
Plan-les-Ouates, CH
Employees
23
Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.
View companyIRLAB Therapeutics
HQ
Göteborg, SE
Employees
30
IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
View company